Results 151 to 160 of about 75,748 (340)

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer

Monaldi Archives for Chest Disease
High blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) have been shown in various malignancies. In lung cancer, the importance of NT-proBNP is not clear. In this study, we aimed to investigate the significance of the correlation of NT-
Sinem İnan, Semra Bilaçeroğlu, Burcu Uludağ Artun   +2 more
doaj   +1 more source

Determinants of NT-proBNP Levels in patients with a systemic right ventricle: a new cut-off level for risk stratification? [PDF]

, 2023
Fiona Tran, Francisco Javier Ruperti‐Repilado, Philip Haaf, Pedro López‐Ayala, Matthias Greutmann, Markus Schwerzmann, Tobias Rutz, Judith Bouchardy, H Stambach, Juerg Schwitter, K Wurstmann, Michael Freese, Christian Mueller, Daniel Tobler   +13 more
openalex   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

Early-pregnancy N-terminal pro-brain natriuretic peptide level is inversely associated with hypertensive disorders of pregnancy diagnosed after 35 weeks of gestation

Scientific Reports
Hypertensive disorders of pregnancy (HDP) are among the major causes of high maternal and fetal/neonatal morbidity and mortality rates. Patients with HDP have significantly elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) levels at diagnosis;
Masaya Takahashi, Luka Suzuki, Nanase Takahashi, Mayu Hanaue, Masahiro Soda, Tamito Miki, Naoko Tateyama, Shiro Ishihara, Taro Koshiishi   +8 more
doaj   +1 more source

The correlation of the peripheral blood NT-proBNP and NF-κB expression levels with the myocardial infarct area and the post-treatment no-reflow in acute myocardial infarction patients.

, 2021
Long Zhang, Yi Hao
openalex   +1 more source

Supplementary Material for: Cardiac troponin T and NT-proBNP for prediction of 30-day readmission or death in patients with acute dyspnea: Data from the Akershus Cardiac Examination 2 Study

, 2023
Rahul Bhatnagar, Kenneth G. Berge, Ragnhild Røysland, A. DidrikHøiseth, Jon Brynildsen, Geir Christensen, Torbjørn Omland, Helge Røsjø, M. NakremLyngbakken   +8 more
openalex   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke

Neurología (English Edition)
Background: Despite comprehensive study, the aetiology of stroke is not identified in 35% of cases. Aims: We conducted a study to assess the diagnostic capacity of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in the identification of ischaemic ...
J.A. García-Carmona, E. Conesa-García, D. Vidal-Mena, M. González-Morales, V. Ramos-Arenas, C. Sánchez-Vizcaíno-Buendía, J.J. Soria-Torrecillas, J.A. Pérez-Vicente, L. García-de-Guadiana-Romualdo   +8 more
doaj   +1 more source

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population

Clinical Interventions in Aging, 2016
Qiwei Zhu,1 Wenkai Xiao,1,* Yongyi Bai,1,* Ping Ye,1 Leiming Luo,1 Peng Gao,1 Hongmei Wu,1 Jie Bai2 1Department of Geriatric Cardiology, 2Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, People’s Republic of China ...
Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J   +7 more
doaj